BRIEF-Hoth Therapeutics Inks Contracts With WuXi STA To Advance Manufacturing Of Cancer Therapeutic
BRIEF-Hoth Therapeutics Inks Contracts With WuXi STA To Advance Manufacturing Of Cancer Therapeutic
Nov 8 (Reuters) - Hoth Therapeutics Inc HOTH.O :
路透11月8日電-Hoth Treateutics Inc HOTH.O：
* HOTH THERAPEUTICS INKS API AND DRUG PRODUCT CONTRACTS WITH WUXI STA TO ADVANCE MANUFACTURING OF HT-KIT CANCER THERAPEUTIC
*Hoth Treeutics與無錫STA簽署原料藥和藥品合同，以推進HT-KIT癌症治療藥物的製造
* HOTH THERAPEUTICS INC - HT-KIT API PROCESS DEVELOPMENT FOR MANUFACTURING IS ALREADY UNDERWAY, EXPECTING TO YIELD SMALL SCALE MATERIAL IN Q1 2022
*Hoth Treateutics Inc-HT-KIT原料藥的製造工藝開發已經在進行中，預計將在2022年第一季度生產小規模材料
* HOTH THERAPEUTICS INC - INTENDS TO DEVELOP HT-KIT AS PARENTERAL FORMULATION FOR INJECTION
*Hoth Treateutics Inc.-打算開發HT-KIT作為注射用的腸外製劑
* HOTH THERAPEUTICS INC - AFTER COMPLETION OF FORMULATION DEVELOPMENT, CO INTENDS TO PURSUE A PRE-IND MEETING WITH US FDA
*Hoth Treateutics Inc-在完成配方開發後，CO打算與美國FDA進行IND前會議
Source text for Eikon: ID:nPn7pcRHra Further company coverage: HOTH.O
Eikon的源文本：ID：nPn7pcRHra進一步的公司報道：HOTH.O
((Reuters.Briefs@thomsonreuters.com;))
(Reurs.Briefs@thomsonreurs.com；)